NANOVEU LIMITED — Capital/Financing Update 2021

May 20, 2021

==> picture [164 x 44] intentionally omitted <==

Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 +61 8 6244 9095 www.nanoveu.com

ASX RELEASE

21 May 2021 ASX: NVU

Expiry of Performance Options

Nanoveu Limited (Nanoveu) hereby advises the following performance options (NVUAJ) were forfeited due to hurdles not being achieved:

Tranche	Performance Rights Hurdle	Number
		Forfeited
	Nanoveu generating US$2,500,000 in revenue from sales of Nanoveu’s
	antiviral protectors for smart phones to customers introduced to Nanoveu
1	by D360 by the later of 31 December 2020 and the date which is 7 months	500,000
	from the date on which Nanoveu announces that Products are available for
	commercial sale.
	Nanoveu generating US$5,000,000 in revenue from sales of Nanoveu’s
	antiviral protectors for smart phones to customers introduced to Nanoveu
2	by D360 by the later of 31 December 2020 and the date which is 7 months	750,000
	from the date on which Nanoveu announces that Products are available for
	commercial sale.
	Nanoveu generating US$20,000,000 in revenue from sales of antiviral
	protectors for smart phones to customers introduced to Nanoveu by D360
3	by the later of 31 December 2021 and the date which is 19 months from	1,000,000
	the date on which Nanoveu announces that Products are available for
	commercial sale.
	Nanoveu generating US$50,000,000 in revenue from sales of antiviral
	protectors for smart phones to customers introduced to Nanoveu by D360
4	by the later of 31 December 2022 or the date which is 31 months from date	1,000,000
	on which Nanoveu announces that Products are available for commercial
	sale.
Total		3,250,000

• Ends -

This announcement has been authorised for release by Nanoveu’s Executive Chairman and CEO

For further information, please For media / investor enquiries, contact: please contact: Alfred Chong David Tasker / Alex Baker Executive Chairman and CEO Chapter One Advisors

t: +65 6557 0155 e: info@nanoveu.com

t: + 61 433 112 936 / +61 432 801 745 e: dtasker@chapteroneadvisors.com.au